Economics of depression and cost-benefit comparisons of selective serotonin reuptake inhibitors and tricyclic antidepressants
- 1 January 1994
- journal article
- research article
- Published by Wiley in Depression
- Vol. 2 (3) , 173-177
- https://doi.org/10.1002/depr.3050020309
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- What Price Depression?The British Journal of Psychiatry, 1994
- Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.BMJ, 1993
- The de Facto US Mental and Addictive Disorders Service SystemArchives of General Psychiatry, 1993
- The costs of depressionInternational Clinical Psychopharmacology, 1993
- The Changing Rate of Major DepressionPublished by American Medical Association (AMA) ,1992
- Depressive Symptoms as Relative and Attributable Risk Factors for First-Onset Major DepressionArchives of General Psychiatry, 1992
- A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patientsThe British Journal of Psychiatry, 1991
- The Functioning and Well-being of Depressed PatientsJAMA, 1989
- The economic burden of depressionGeneral Hospital Psychiatry, 1986